Renaissance BioScience (RBSC) has strategically partnered with the Vaccine and Infectious Disease Organization (VIDO), a world leader in infectious disease research and vaccine development. Through a $600,000 award by the Saskatchewan Agricultural Development Fund, the collaboration will target two diseases, as well as immune system function, in pigs and piglets using Renaissance’s cutting-edge yeast-based technology, the company announced in a release.
Heather Wilson, a prominent scientist and program leader in vaccine formulation and delivery, will coordinate the two distinct projects at VIDO. Both projects aim to develop cost-effective, safe, non-invasive health solutions that can be conveniently included in the pig’s feed.
“We are enthusiastic about working with Renaissance and its highly experienced yeast experts and technologies to address these vital livestock health concerns. This yeast platform technology holds significant promise in improving animal health, and we look forward to getting started on these projects," she said.
RBSC and VIDO will pioneer orally delivered yeast-based vaccines for porcine epidemic diarrheal virus (PEDV) and porcine reproductive and respiratory syndrome virus (PRRSV) in the first project, the release explained.